East Valley Hematology and Oncology Medical Group Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2003
NCT00131313
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2003

Timeline

NOW
  • Now

Alternative names

Mena, Raul, M.D.

Active Ingredients

Drugs in Phase 4 Trials (3)

cyclophosphamide (cytoxan) (1 trial)

pentostatin (nipent) (1 trial)

rituximab (rituxan) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Leukemia (Phase 4)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 4)

Leukemia, Lymphoid (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 3